What is she best known for?
The fields of study she is best known for:
Sylvie Mader focuses on Molecular biology, Cell biology, Nuclear receptor, Gene and Estrogen receptor.
Her work deals with themes such as Reporter gene, Gene expression, Coactivator, LCOR and Calcitriol receptor, which intersect with Molecular biology.
Her work carried out in the field of Cell biology brings together such families of science as Retinoid X receptor alpha, Retinoid X receptor and Biochemistry.
Her Retinoid X receptor alpha research incorporates elements of Retinoid X receptor beta, Thyroid hormone receptor, Retinoid receptor, Retinoid X receptor gamma and Nuclear protein.
Her Nuclear receptor study combines topics from a wide range of disciplines, such as Histone deacetylase, Trichostatin A and Estrogen receptor alpha.
Her studies deal with areas such as Transcription, Human genome and Binding site as well as Estrogen receptor.
Her most cited work include:
- Cutting Edge: 1,25-dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression (1185 citations)
- Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently (1003 citations)
- Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently (1003 citations)
What are the main themes of her work throughout her whole career to date?
Sylvie Mader mostly deals with Cancer research, Molecular biology, Cell biology, Estrogen receptor and Nuclear receptor.
Her Molecular biology research incorporates themes from Expression vector, Retinoic acid, Promoter, Transcription and Corepressor.
Her Cell biology study integrates concerns from other disciplines, such as Coactivator, Receptor, Biochemistry and Transactivation.
Her Nuclear receptor study is focused on Transcription factor and Genetics.
Her research integrates issues of Thyroid hormone receptor and Retinoid X receptor alpha in her study of Retinoid X receptor.
Her research investigates the connection between Retinoid X receptor alpha and topics such as Retinoid receptor that intersect with issues in Nuclear protein.
She most often published in these fields:
- Cancer research (27.27%)
- Molecular biology (27.27%)
- Cell biology (29.75%)
What were the highlights of her more recent work (between 2012-2021)?
- Cancer research (27.27%)
- Breast cancer (11.57%)
- Estrogen receptor (28.10%)
In recent papers she was focusing on the following fields of study:
Sylvie Mader mainly focuses on Cancer research, Breast cancer, Estrogen receptor, Cancer and Nuclear receptor.
Her Cancer research study incorporates themes from Small hairpin RNA, Estrogen, Immune system and Estrogen receptor alpha.
Her Estrogen receptor research includes elements of Histone deacetylase, Entinostat, HDAC6 and Biochemistry.
Her Nuclear receptor research includes themes of Luciferase, Receptor and Cell biology.
Sylvie Mader has researched Receptor in several fields, including Coactivator, Retinoid, Retinoid X receptor and Yellow fluorescent protein.
Sylvie Mader interconnects Psychological repression and Mutant in the investigation of issues within Cell biology.
Between 2012 and 2021, her most popular works were:
- MHC class I–associated peptides derive from selective regions of the human genome (116 citations)
- Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription. (33 citations)
- Antiestrogens: structure-activity relationships and use in breast cancer treatment. (32 citations)
In her most recent research, the most cited papers focused on:
Sylvie Mader spends much of her time researching Breast cancer, Estrogen receptor, Cancer research, Estrogen receptor alpha and Pathology.
Her Estrogen receptor research is multidisciplinary, incorporating elements of Histone deacetylase, Histone deacetylase inhibitor, Entinostat and Biochemistry.
Her research in Cancer research intersects with topics in HDAC3, Benzamide and HDAC6.
Her Estrogen receptor alpha study combines topics in areas such as Tamoxifen, Fulvestrant and Estrogen.
Sylvie Mader combines subjects such as Triple-negative breast cancer, microRNA and CA15-3 with her study of Pathology.
Her biological study spans a wide range of topics, including Gene expression and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
